Future Health ESG Corp.
FHLT · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.60 | 6.51 | -2.45 | 1.11 |
| FCF Yield | -0.20% | -0.09% | -0.53% | -0.24% |
| EV / EBITDA | -632,296.26 | 0.00 | -612.62 | -260.41 |
| Quality | ||||
| ROIC | -2.45% | -0.40% | -0.38% | -1.57% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 2.37 | -0.95 | -7.56 | 1.52 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -119.99% | 82.50% | -126.69% | 41.99% |
| Safety | ||||
| Net Debt / EBITDA | 1,078.78 | 0.00 | 2.91 | 2.74 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |